1-3 of 3
Brian J. Czerniecki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4+ Th1 Responses and Potential Use as a Cancer Vaccine

Amrita Basu, Gabriella K. Albert, Sabrina Awshah, Jashodeep Datta, Krithika N. Kodumudi, Corey Gallen, Amber Beyer, Keiran S.M. Smalley, Paulo C. Rodriguez, Derek R. Duckett, Peter A. Forsyth, Aixa Soyano, Gary K. Koski, Ricardo Lima Barros Costa, Heather Han, Hatem Soliman, Marie Catherine Lee, Pawel Kalinski, Brian J. Czerniecki
Journal: Cancer Immunology Research
Cancer Immunol Res (2022) 10 (1): 108–125.
https://doi.org/10.1158/2326-6066.CIR-21-0454
Published: 01 January 2022
View article titled, Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4<sup>+</sup> Th1 Responses and Potential Use as a Cancer Vaccine
Open the PDF for Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4<sup>+</sup> Th1 Responses and Potential Use as a Cancer Vaccine in another window
Includes: Supplementary data
Journal Articles

Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity

Manali S. Phadke, Zhihua Chen, Jiannong Li, Eslam Mohamed, Michael A. Davies, Inna Smalley, Derek R. Duckett, Vinayak Palve, Brian J. Czerniecki, Peter A. Forsyth, David Noyes, Dennis O. Adeegbe, Zeynep Eroglu, Kimberly T. Nguyen, Kenneth Y. Tsai, Uwe Rix, Christin E. Burd, Yian A. Chen, Paulo C. Rodriguez, Keiran S.M. Smalley
Journal: Cancer Immunology Research
Cancer Immunol Res (2021) 9 (5): 554–567.
https://doi.org/10.1158/2326-6066.CIR-20-0905
Published: 01 May 2021
View article titled, Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity
Open the PDF for Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity in another window
Includes: Supplementary data
Journal Articles

CD4+ T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8+ T-cell Targeting of HER2/neu–Expressing Cancers

Jashodeep Datta, Shuwen Xu, Cinthia Rosemblit, Jenessa B. Smith, Jessica A. Cintolo, Daniel J. Powell, Jr, Brian J. Czerniecki
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (5): 455–463.
https://doi.org/10.1158/2326-6066.CIR-14-0208
Published: 03 May 2015
View article titled, CD4<sup>+</sup> T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8<sup>+</sup> T-cell Targeting of HER2/<em>neu</em>–Expressing Cancers
Open the PDF for CD4<sup>+</sup> T-Helper Type 1 Cytokines and Trastuzumab Facilitate CD8<sup>+</sup> T-cell Targeting of HER2/<em>neu</em>–Expressing Cancers in another window
Includes: Supplementary data